T-cell lines specific for peptides of adenovirus hexon protein and devoid of alloreactivity against recipient cells can be obtained from HLA-haploidentical donors

Journal of Immunotherapy

Volumn 31, Issue 6, 2008, Pages 529-536

  Comoli, Patrizia ^a   Schilham, Marco W ^b   Basso, Sabrina ^a   Van Vreeswijk, Tamara ^b   Bernardo, Maria Ester ^a   Maccario, Rita ^a   Van Tol, Maarten J D ^b   Locatelli, Franco ^a   Veltrop Duits, Louise A ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adenovirus infection; Adoptive immunotherapy; Pediatric HSCT; T cell lines

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; HEXON PROTEIN; HLA ANTIGEN; P64 PROTEIN; PROTEIN P42; PROTEIN P50; PROTEIN P57; PROTEIN P60; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN; CAPSID PROTEIN; HEXON CAPSID PROTEIN, ADENOVIRUS;

ADOPTIVE IMMUNOTHERAPY; ALLOIMMUNITY; ANTIVIRAL ACTIVITY; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL SPECIFICITY; CONTROLLED STUDY; CYTOTOXICITY; DONOR; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HAPLOIDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; HUMAN ADENOVIRUS 5; HUMAN CELL; IN VITRO STUDY; INTERFERON PRODUCTION; LYMPHOCYTE CULTURE; LYMPHOCYTE DEPLETION; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SCALE UP; T LYMPHOCYTE; VALIDATION PROCESS; BIOSYNTHESIS; CELL LINE; HAPLOTYPE; HISTOCOMPATIBILITY TEST; IMMUNOLOGY;

CAPSID PROTEINS; CELL LINE; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERFERON TYPE II; T-LYMPHOCYTES; TISSUE DONORS;

EID: 48549101673     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/CJI.0b013e31817b9c6b     Document Type: Article

References (25)

1. Shields AF, Hackman RC, Fife KH, et al. Adenovirus infections in patients undergoing bone marrow transplantation. N Engl J Med. 1985;312:529-533.
2. Flomenberg P, Babbitt J, Drobyski WR, et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis. 1994;169:775-781.
3. Blanke C, Clark C, Broun ER, et al. Evolving pathogens in allogeneic bone marrow transplantation: increased fatal adenoviral infections. Am J Med. 1995;99:326-328.
4. Walls T, Shankar AG, Shingadia D. Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infect Dis. 2003;3:79-86.
5. Howard D, Phillips G, Reece D, et al. Adenovirus infections in haematopoietic stem cell transplant recipients. Clin Infect Dis. 1999;29:1494-1501.
6. Chakrabarti S, Mautner V, Osman H, et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression and immune recovery. Blood. 2002;100:1619-1627.
7. Lion T, Baumgartinger R, Watzinger F, et al. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood. 2003;102:1114-1120.
8. van Tol MJD, Kroes ACM, Schinkel J, et al. Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery. Bone Marrow Transplant. 2005;36:39-50.
9. Chakrabarti S, Milligan DW, Moss PAH, et al. Adenovirus infections in stem cell transplant recipients: recent developments in understanding of pathogenesis, diagnosis and management. Leuk Lymph. 2004;45:885.
10. Leen AM, Bollard CM, Myers GD, et al. Adenoviral infections in haematopoietic stem cell transplantation. Biol Bone Marrow Transplant. 2006;12:243-251.
11. Lankester AC, Heemskerk B, Claas ECJ, et al. Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection. Clin Infect Dis. 2004;38:1521-1525.
12. Muller WJ, Levin MJ, Shin YK, et al. Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients. Clin Infect Dis. 2005;41:1812-1816.
13. Neofytos D, Ojha A, Mookerjee B, et al. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Bone Marrow Transplant. 2007;13:743-781.
14. Heemskerk B, Lankester AC, van Vreeswijk T, et al. Immune reconstitution and clearance of human adenovirus viremia in pediatric stem cell recipients. J Infect Dis. 2005;191 520-530.
15. Feuchtinger T, Matthes-Martin S, Richard C, et al. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol. 2006;134:64-76.
16. Leen AM, Myers GD, Sili U, et al. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat Med. 2006;12:1160-1166.
17. Veltrop-Duits LA, Heemskerk B, Sombroek CC, et al. Human CD4+ T cells stimulated by conserved adenovirus 5 hexon peptides recognize cells infected with different species of human adenovirus. Eur J Immunol. 2006;36:2410-2423.
18. Perruccio K, Tosti A, Burchielli E, et al. Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood. 2005;106:4397-4406.
19. Comoli P, Basso S, Zecca M, et al. Preemptive therapy of EBVrelated lymphoproliferative disease after pediatric haploidentical stem cell transplantation. Am J Transplant. 2007;7:1648-1655.
20. Olive M, Eisenlohr L, Flomenberg N, et al. The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope. Hum Gene Ther. 2002;13:1167-1178.
21. Leen AM, Sili U, Savoldo B, et al. Fiber-modified adenoviruses generate subgroup cross-reactive adenovirus-specific cytotoxic T-lymphocytes for therapeutic applications. Blood. 2004;103: 1011-1119.
22. Heemskerk B, Veltrop-Duits LA, van Vreeswijk T, et al. Extensive cross-reactivity of CD4- adenovirus-specific T cells: implications for immunotherapy and gene therapy. J Virol. 2006;77:6562-6566.
23. Leen AM, Sili U, Vanin EF, et al. Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells. Blood. 2004;104:2432-2440.
24. Einsele H, Roosnek E, Rufer N, et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood. 2002;99:3916-3922.
25. Heemskerk B, van Vreeswijk T, Veltrop-Duits LA, et al. Adenovirus- specific CD4+ T cell clones recognizing endogenous antigen inhibit viral replication in vitro through cognate interaction. J Immunol. 2006;177:8851-8859.